Revisiting the white blood cell count: Immature granulocytes count as a diagnostic marker to discriminate between SIRS and sepsis - a prospective, observational study

BMC Immunology

Volumn 14, Issue 1, 2013, Pages

  Nierhaus, Axel ^a   Klatte, Stefanie ^b   Linssen, Jo ^b   Eismann, Nina M ^a   Wichmann, Dominic ^a   Hedke, Jörg ^a   Braune, Stephan A ^a   Kluge, Stefan ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b SYSMEX CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE BINDING PROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMATURE GRANULOCYTE COUNT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GERMANY; GRANULOCYTES; HUMANS; INTENSIVE CARE UNITS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; ODDS RATIO; PROGNOSIS; PROSPECTIVE STUDIES; SEPSIS; YOUNG ADULT;

EID: 84873700349     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-14-8     Document Type: Article

References (43)

1. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American college of chest physicians/society of critical care medicine. Chest 1992, 101(6):1644-1655. 10.1378/chest.101.6.1644, 1303622.
2. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med 2001, 29(4):530-538.
3. Schoenberg MH, Weiss M, Radermacher P. Outcome of patients with sepsis and septic shock after ICU treatment. Langenbecks Arch Surg 1998, 383(1):44-48. 10.1007/s004230050090, 9627170.
4. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348(16):1546-1554. 10.1056/NEJMoa022139, 12700374.
5. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345(19):1368-1377. 10.1056/NEJMoa010307, 11794169.
6. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995, 273(2):117-123. 10.1001/jama.1995.03520260039030, 7799491.
7. Castelli GP, Pognani C, Cita M, Stuani A, Sgarbi L, Paladini R. Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis. Minerva Anestesiol 2006, 72(1-2):69-80.
8. Iapichino G, Marzorati S, Umbrello M, Baccalini R, Barassi A, Cainarca M, Colombo Pavini F, Mantovani E, Mauri A, Moroni B, Noto A, Melzi D'eril GV, Langer M. Daily monitoring of biomarkers of sepsis in complicated long-term ICU-patients: can it support treatment decisions?. Minerva Anestesiol 2010, 76(10):814-23.
9. Buttenschoen K, Buttenschoen DC, Berger D, Vasilescu C, Schafheutle S, Goeltenboth B, Seidelmann M, Beger HG. Endotoxemia and acute-phase proteins in major abdominal surgery. Am J Surg 2001, 181(1):36-43. 10.1016/S0002-9610(00)00534-1, 11248174.
10. Shin HS, Xu F, Bagchi A, Herrup E, Prakash A, Valentine C, Kulkarni H, Wilhelmsen K, Warren S, Hellman J. Bacterial lipoprotein TLR2 agonists broadly modulate endothelial function and coagulation pathways in vitro and in vivo. J Immunol 2011, 186(2):1119-1130. 10.4049/jimmunol.1001647, 3482611, 21169547.
11. Martin C, Boisson C, Haccoun M, Thomachot L, Mege JL. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med 1997, 25(11):1813-1819. 10.1097/00003246-199711000-00018, 9366763.
12. Oberhoffer M, Vogelsang H, Russwurm S, Hartung T, Reinhart K. Outcome prediction by traditional and new markers of inflammation in patients with sepsis. Clin Chem Lab Med 1999, 37(3):363-368.
13. Engler R. Acute-phase proteins in inflammation. C R Seances Soc Biol Fil 1995, 189(4):563-578.
14. Grube BJ, Cochane CG, Ye RD, Green CE, McPhail ME, Ulevitch RJ, Tobias PS. Lipopolysaccharide binding protein expression in primary human hepatocytes and HepG2 hepatoma cells. J Biol Chem 1994, 269(11):8477-8482.
15. Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schuttler J. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 1998, 24(7):680-684. 10.1007/s001340050644, 9722037.
16. Brunkhorst FM, Clark AL, Forycki ZF, Anker SD. Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: the potential importance of bacterial translocation. Int J Cardiol 1999, 72(1):3-10. 10.1016/S0167-5273(99)00118-7, 10636626.
17. Castelli GP, Pognani C, Cita M, Paladini R. Procalcitonin as a prognostic and diagnostic tool for septic complications after major trauma. Crit Care Med 2009, 37(6):1845-1849. 10.1097/CCM.0b013e31819ffd5b, 19384224.
18. Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, Tobias PS, Ulevitch RJ. Structure and function of lipopolysaccharide binding protein. Science 1990, 249(4975):1429-1431. 10.1126/science.2402637, 2402637.
19. Gaini S, Koldkjaer OG, Moller HJ, Pedersen C, Pedersen SS. A comparison of high-mobility group-box 1 protein, lipopolysaccharide-binding protein and procalcitonin in severe community-acquired infections and bacteraemia: a prospective study. Crit Care 2007, 11(4):R76. 10.1186/cc5967, 2206511, 17625012.
20. Prucha M, Herold I, Zazula R, Dubska L, Dostal M, Hildebrand T, Hyanek J. Significance of lipopolysaccharide-binding protein (an acute phase protein) in monitoring critically ill patients. Crit Care 2003, 7(6):R154-R159. 10.1186/cc2386, 374378, 14624690.
21. Adamzik M, Eggmann M, Frey UH, Gorlinger K, Brocker-Preuss M, Marggraf G, Saner F, Eggebrecht H, Peters J, Hartmann M. Comparison of thromboelastometry with procalcitonin, interleukin 6, and C-reactive protein as diagnostic tests for severe sepsis in critically ill adults. Crit Care 2010, 14(5):R178. 10.1186/cc9284, 3219282, 20929576.
22. Weiland T, Kalkman H, Heihn H. Evaluation of the automated immature granulocyte count (IG) on Sysmex XE-2100 automated haematology analyser vs. visual microscopy (NCCLS H20-A). Sysmex J Int 2002, 12(2):63-70.
23. Ansari-Lari MA, Kickler TS, Borowitz MJ. Immature granulocyte measurement using the Sysmex XE-2100. Relationship to infection and sepsis. Am J Clin Pathol 2003, 120(5):795-799. 10.1309/LT30BV9UJJV9CFHQ, 14608908.
24. Nigro KG, O'Riordan M, Molloy EJ, Walsh MC, Sandhaus LM. Performance of an automated immature granulocyte count as a predictor of neonatal sepsis. Am J Clin Pathol 2005, 123(4):618-624. 10.1309/73H7K7UBW816PBJJ, 15743752.
25. Bender L, Thaarup J, Varming K, Krarup H, Ellermann-Eriksen S, Ebbesen F. Early and late markers for the detection of early-onset neonatal sepsis. Dan Med Bull 2008, 55(4):219-223.
26. Smith JA. Neutrophils, host defense, and inflammation: a double-edged sword. J Leukoc Biol 1994, 56(6):672-686.
27. Panopoulos AD, Watowich SS. Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis. Cytokine 2008, 42(3):277-288. 10.1016/j.cyto.2008.03.002, 2852428, 18400509.
28. Selig C, Nothdurft W. Cytokines and progenitor cells of granulocytopoiesis in peripheral blood of patients with bacterial infections. Infect Immun 1995, 63(1):104-109. 172964, 7528729.
29. Thijs LG, Hack CE. Time course of cytokine levels in sepsis. Intensive Care Med 1995, 21(Suppl 2):S258-S263.
30. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 2003, 56(11):1129-1135. 10.1016/S0895-4356(03)00177-X, 14615004.
31. Vincent JL. Organ dysfunction in patients with severe sepsis. Surg Infect (Larchmt) 2006, 7(Suppl 2):S69-S72.
32. Vosylius S, Sipylaite J, Ivaskevicius J. Sequential organ failure assessment score as the determinant of outcome for patients with severe sepsis. Croat Med J 2004, 45(6):715-720.
33. Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomes RN, Bozza MT, Castro-Faria-Neto HC, Bozza PT. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 2007, 11(2):R49. 10.1186/cc5783, 2206478, 17448250.
34. Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, Fine J, Krichevsky A, Delude RL, Angus DC. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the genetic and inflammatory markers of sepsis (GenIMS) study. Arch Intern Med 2007, 167(15):1655-1663. 10.1001/archinte.167.15.1655, 17698689.
35. Silvestre J, Povoa P, Coelho L, Almeida E, Moreira P, Fernandes A, Mealha R, Sabino H. Is C-reactive protein a good prognostic marker in septic patients?. Intensive Care Med 2009, 35(5):909-913. 10.1007/s00134-009-1402-y, 19169668.
36. Villar J, Perez-Mendez L, Espinosa E, Flores C, Blanco J, Muriel A, Basaldua S, Muros M, Blanch L, Artigas A, Kacmarek RM. Serum lipopolysaccharide binding protein levels predict severity of lung injury and mortality in patients with severe sepsis. PLoS One 2009, 4(8):e6818. 10.1371/journal.pone.0006818, 2730016, 19718443.
37. Liaudat S, Dayer E, Praz G, Bille J, Troillet N. Usefulness of procalcitonin serum level for the diagnosis of bacteremia. Eur J Clin Microbiol Infect Dis 2001, 20(8):524-527. 10.1007/s100960100548, 11681430.
38. National Committee for Clinical Laboratory Standards (NCCLS) Reference leukocyte differential count (proportional) and evaluation of instrumental methods 1992, Wayne, PA: NCCLS Document H20-A 1, National Committee for Clinical Laboratory Standards (NCCLS).
39. Bruegel M, Fiedler GM, Matthes G, Thiery J. Reference values for immature granulocytes in healthy blood donors generated on the Sysmex XE-2100 automated hematology analyser. Sysmex J Int 2004, 14(1):5-7.
40. Fernandes B, Hamaguchi Y. Automated enumeration of immature granulocytes. Am J Clin Pathol 2007, 128(3):454-463. 10.1309/TVGKD5TVB7W9HHC7, 17709320.
41. Mardi D, Fwity B, Lobmann R, Ambrosch A. Mean cell volume of neutrophils and monocytes compared with C-reactive protein, interleukin-6 and white blood cell count for prediction of sepsis and nonsystemic bacterial infections. Int J Lab Hematol 2010, 32(4):410-418.
42. Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a european/north american multicenter study. JAMA 1993, 270(24):2957-2963. 10.1001/jama.1993.03510240069035, 8254858.
43. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine. Intensive Care Med 1996, 22(7):707-710. 10.1007/BF01709751, 8844239.